Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2014; 20(9): 2412-2419
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2412
Table 1 Characteristics of the 12 randomized controlled trials included in this meta-analysis of the effects of combined prokinetic and proton pump inhibitor therapy in gastroesophageal reflux diseases n (%)
Ref.CountryParticipants (n)Duration of studyFemaleAge (yr)BMI (kg/m2)
Vakil et al[23], 2013United States4606 wk254 (55.2)4428
Cho et al[24], 2013South Korea504 wk26 (52.0)4621
Shaheen et al[28], 2013United States6614 wk376 (56.9)4828
Ndraha et al[29], 2011Indonesia602 wk40 (66.7)4224
Hsu et al[2], 2010Taiwan968 wk48 (50.0)4724
Boeckxstaens et al[22], 2011United States2444 wk82 (33.6)5027
Miwa et al[12], 2011Japan2004 wk120 (60.0)5222
Beaumont et al[27], 2009United States162 wk8 (50.0)54Not reported
Madan et al[19], 2004India688 wk23 (33.8)35Not reported
Smythe et al[30], 2003United Kingdom234 wk3 (13.0)62Not reported
van Rensburg et al[25], 2001United Kingdom3508 wk213 (60.9)4728
Vigneri et al[26], 1995Italy17512 mo58 (33.1)45Not reported